1．郭定九易凡，譯.皮膚免疫病理學(xué).1980年,長沙
2.SerreG, Viocent C , et al. Natural IgM and Igg autoantibodies to epidermal keratinsin normal human sera：I ELISA titration immunofluorecence study. J Invest Dermatol, 1987, 88：21～27
3.王剛,等.抗角蛋白自身抗體的研究進展．國外醫(yī)學(xué)(皮膚病學(xué)分冊),1982,18(2)：74
4.聶祝湘,等.天皰瘡抗體及其臨床意義.臨床皮膚病科雜志,1991,20(6)：317～319
5. 聶祝湘,等.天皰瘡治療的某些進展.國外醫(yī)學(xué)(皮膚病學(xué)分冊),1991, 17(5)：265～268
6.ThompsonC, et al. Expression of blood group antigen by cultured human epidermal cells.J Invest Dermatol, 1986, 86：394～398
7.jANdBos. sis . keratinocyte p 75, CTC Press, Inc . Florida AM, 1989
8. 白兆霞,等.尖銳濕疣病損的免疫組化研究.中華皮膚科雜志,1992, 25：247
9.趙玉銘,等.HLA抗原在正常皮膚中的分布.中華皮膚科雜志,1991, 23(6)：402
10. VanLis JM , et al. Cin- Areaction with plasma membrane in human epidermsi. Am JClin Pathol, 1983, 779(1)：143～4
11.Hashimoto K, etal. A Lectin – binding glyciprotein of Mr 135000 associated withbasal keratinocyte in pig epidermis. Biochem J, 1986,237(2)：405～414
12.唐書謙,等.不同底物對大皰性皮膚病間接免疫熒光的評價評價.中華皮膚科雜志,1988,22(1)：36
13. 劉榮卿,等.天皰瘡及大皰性類天皰瘡外觀正常皮膚的免疫熒光檢查.中華皮膚f1411.cn/zhuyuan/科雜志,1987,20：138
14. 聶祝湘,等.止血芳酸治療天皰瘡的實驗觀察.中華皮膚科雜志,1992, 25(4)：256～258
15. WickMR and Scheithauer. Primary neuroendocrine carcinoma of the skin. In ：Pathology oof Unsual MalignantCutaneous Tumors. Wick MR ed. Ne W Yorh. Marcel Dekker INC, 1985. 107
16.Narisawa Y, Hashimoto K, Bayless T, et al. Cytokeratin polypeptide Profile ofmerkel cells in human fetal and adult skin：difference of expression of cytokeratins inepidermal and dermal merkle cells. j Invest Dermatol, 1992, 98：171
17.Narisawa Y , Hashimoto K, Nihei Y, et al. Biological significance of dermalmerkle cells in development of cutaneous nerves in human fetal skin. J HistchemCytochem, 1992；40：65
18. 劉榮卿唐書謙徐潔芳,等.天皰瘡及大皰性類天皰瘡?fù)庥^正常皮膚的免疫熒光檢查.中華皮膚科雜志,1987,20(3)：138～140
19. 刁慶春劉榮卿唐書謙.天皰瘡、類天皰瘡自身抗體檢測的臨床意義。中華皮膚科雜志，1988，21（5)：283
20．朱學(xué)駿niimi YJ Bystryn JC.大皰性類天皰瘡抗原分子異質(zhì)性。中華皮膚科雜志，1990，23：291～293
21．靳培英是元甫。皰疹樣皮炎在我國的發(fā)病情況及其診斷標(biāo)準(zhǔn)的商榷.中華皮膚科雜志,1991,24(4)：232～235
22．Prost G, et al. Diagnosis of adultlinear IgA dermatosis by immuno ╟ electromicroscopy in 16 patients withlinear IgA deposits. J Invest Dermatol,f1411.cn/shouyi/1989, 92(1)：39～45
23.wojnarowska F, Marsden RA, Bhogal B, et al. Chronic bullous disease ofchildhood, childhood cicatricial pemphigoif, and linear Iga disease of adults.A comparative study demonsrating clinical and immunopathologic overlap. J AmAcad Dermatol, 1988, 19(5)：792～805
24. 朱學(xué)駿Niimi YJ Bystryn JC.抗基底膜帶抗體陽性血清患者中獲得性大皰性表皮松解癥的發(fā)生率.臨床皮膚科雜志,1990,19(4)：170～173
25.Akutsu Y and Jimbow K. Immunoelectron microscopic demonstration of humanmelanosome associated antigens (HMSA) on melanoma cells：Comparison with tyrosinasedistribution. J Invest Dermatol, 1988, 90：179
26.NakanishiT and Hashimoto K. The differential reactive of benign and malignantnevomelanecytic lesions with mouse monoclonal antibody TNKH1. Cancer, 1987, 50：1340
27. ImamA, Mitchell MS, Modlin RL, et al. Human monoclonal antibodies that distinguishcutaneous malignant melanomas form benign nevi in fixed Tissue sections. JInvest Dermatol, 1986, 86：145
28. GownAM, Vogel AM, Hoak M , et al. Monoclonan antibodies specific for melanocytictumors distinguish subpopulations of melanocytes. Am j Pathol, 1986, 123：195
29.Schaumburg - Lever G, Metzler G, Kaiserling E.Ultrastructural localization ofHMB –45 binding sites. J Cutan Pathol, 1991,18：432
30. 天高文葉慶佾劉榮卿.異常黑素小體在惡性黑素瘤診斷中的意義.第三軍醫(yī)大學(xué)學(xué)報,1992,14(4)：323
31.Furukawa K and Lloyd KO. Gangliosides in melanoma. IN：Human Melanoma. From Basicresearch to dinical application. Ferrone S ed. New York Springer –Verlag, 1990：15
32.Taniguchi M, Kuwabara I, Harada Y, et al. Cross ╟ species melanoma antigen. 1990.
33.Werkmeister JA, Triglia T, Mackay IR, et al. Fluctuations in the expression ofa glyolipid antigen assocted with differentiation of melanoma cells monitoredby a monoclonal antibody , Leo Me13. Cancer Res, 1987,47：225
34. 田芳金伯泉黃傳書,等.抗人黑素瘤單克隆抗體免疫組化的研究.單克隆抗體通迅,1991,7：21
35. EstinCD, Plowman CD, Rose TM, et al. Characterization of P97, a humanmelanoma -associated antigen, and development of a recombinant vaccien formelanoma. In：Human Melanoma. From basic research to clinical application . FerroneSed. New York. Springer –Verlag, 1990.87
36.高天文劉榮卿葉慶佾.無色素性惡性黑素瘤免疫組化診斷研究.中華皮膚科雜志,1992, 25：222
37. 劉榮卿高天文.無色素性惡性黑素瘤的診斷探討.實用腫瘤雜志,1992,7：152
38.NagataH, Ueki H, Moriguchi T, et al. Fibronectin,localization in normal human skin,granulation tissue, hypertropic scar, maure scar, progressive systemicsclerotic skin, and other fibrosing dermatoses. Arch Dermatol, 1985, 121(8)：995～999
39.Linares HA. Protroglycan – lymphocyte association in the development ofhypertrophic scars. Burns, 1990, 16(1)：21～24
40.Branchet MC, Boisnic S, Bletry O, et al. Exxpression of HLA class II antigensonskin fibroblasts in scleroderma. Br J Dermatol, 1992,12(5)：431～435
41.CastagnoliC, Stella M, Magliacani G, et al. Anomalous expression of HLA class IImolecules on kerattinocytes and fibroblasts in hypdrtropgicscars consequent tothermal injury. Clin Exp Immunol, 1990, 82(2)：350～354
42.Needleman BW, Increased expression of intercellular adhesion molecule 1 on thefibroblasts of scleroderma patientl. Arthritis Rheum,1990, 33(12)：1847～1851
43.Skalli U, Schurch W, Seemayer T, et al. Myofibrollasts from diverse pathologicsetting are heterogeneous in their content of actin isoforms and intermediatefilament proteins. Lab Invest, 1989, 60(2)：275
44.Sollberg S, Peltonen J, Uitto J, et al. Elevated expressoin of β２and β2integrins, intercellularadhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skinof patients with sysytemic sclerosis of recent onset .Arthritis Rheum, 1992；35(3)：290～298
45. GayS, Jones RE, Huang GQ, et al. Immunohistologic demonstration of platelet -derives growth factor and sis – oncogene expression in scleroderma. J InvestDermatol, 1989, 92(2)：301～303
46.Klareskog L, Gustafsson R, Scheynius A, et al. Increased expression of platelet– derives growth factor type B receptors in the skin of patients with systemicsclerosis. Arthritis Rheum, 1990, 94(2)：197～203
47.Gruschwitz M, Muller PU, Sepp N, et al. Transcription and expression oftransforming growth factor type beta in the skin of progressive systemicsclerosis：amediator of fibrosis? J Invest Dermatol, 1990, 94(2)：197～203
48.Peltonen J, Hsiao LL, Jaakkola S, et al. Activation of collagengene expressionin keloids ：colocalization of type I and IV collagen and transforming growth factor–β1mRNA.J Invest Dermatol, 1991；97(2)：240～248
49.TraniAMA, Gruber BL, Kaufman LD, et al. Mast cell changes in scleroderma. ArthritisRheum, 1992；35(8)：933～939
50.Hashimoto K, et al. Anti – keratin monoclonal antibodies ：production, specificities andapplications. J Cutan Pathol, 1983；6(10)：529～539
51.KallioinenM, et al. β-2-microglobulin in benign and malignant adnexal skin tumors andmetastasizing basocellular carcinoma. J Cutan Pathol, 1984；1(11)：27～34
52.Penney NS. Immunohistochemistry of adnexal neoplasms. j Cutan Pathol , 1984；(11)：357～364
53.SwansonPE, et al. Eccrine sweat gland carcarcinoma：an histologic and immunohistochemical studyof 32 cases. J Cutan Pathol,1987,2(4)：65～86
54. NodaY, et al. Immunohistochemical study of carbonic anhydrase in mixed tumors andadenomas of sweat and sebaceous glands. J Cutan Pathol, 1987；5(14)：285～290
55.NodaY,et al. Immunohistochemical localization by monoclonal antibody of humanepidermal growth factor in mixed tumors of the skin. J Cutan Pathol, 1987；6(14)：337～342
56. ZukJA, et al. Immunohistochemistry staining patterns of sweat glands and theirneoplasms using two nomoclonal antibodies to keratieos. j Cutan Pathol, 1988；1(15)：8～17
57.MazoujianG, et al. Immunohistochemistry of gross disease fluid protein (GCDFP-15) in 65benign sweat gland tumors of the skin. Am j Dermatopathol, 1988, 1(10)：28～35
58. WoodWS, et al. Mammary Paget’s disease and intraductal carcinoma ：histologic, histologic,histochemical and immunocytochemical comparison. Am j Dermatopathol, 1988,10(3)：188
59.Mihara M. Chondroid syringoma associated with hidrocystoma – like changes ：possible differentiation intoeccring gland：a histologic. immunohistochemical and electron microscopic study. JCutan Pathol, 1989, 5(16)：281～286
60.Penneys NS, et al. Immunohistochemistry demonstration of ferritin in sweatgland and sweat gland neoplasms. J Cutan Pathol, 1990, 1(17)：32～36
61. UranoY, et al. Immunohistochemistry demonstration of petidylarginine deiminase inhuman sweat glands. Am J Dermatopathol, 1990；12(3)：249～255
62.Mazoujian G. Immunohistochemistry of GCDFP –24 and zinic alpha2 glycoprotein inbenign sweat gland tumors. Am J Dermatopathol,1990, 12(5)：452～457
